학술논문

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist.
Document Type
Article
Source
European Journal of Medicinal Chemistry. Mar2023, Vol. 250, pN.PAG-N.PAG. 1p.
Subject
*DRUG development
*DNA damage
*NATURAL immunity
*PEPTIDE antibiotics
*DIMERIZATION
*IMMUNE response
*VENOM
*SCORPION venom
Language
ISSN
0223-5234
Abstract
Cyclic GMP-AMP synthase and stimulator of interferon genes (cGAS-STING) signaling stimulators, an essential innate immunity component, monitor invading pathogen DNA and damaged self-DNA, making them an appealing target for drug development. The natural STING agonist, 2′3′-cGAMP, mounts and stabilizes the STING homodimer to trigger an antiviral or antitumor immune responses. However, cyclic-dinucleotide-based STING agonists show limited clinical effects owing to their short half-lives. To explore whether STING-dimer stabilizers could trigger STING signaling instead of cyclic dinucleotide-based molecules, we analyzed the structural characteristics of STING to design and synthesize a series of compounds based on the covalent STING inhibitor C-170, three of which were 23 , 26 , and 27 , exhibited STING-dependent immune activation, both in vitro and in vivo. Compound 23 could act synergistically with cGAMP and other STING agonists as a promising moderate STING agonist. This indicates that promoting STING dimerization is a promising strategy for designing next-generation STING agonists. [Display omitted] • A bimolecular STING agonist based on the reported STING covalent inhibitor. • Stimulate STING by increasing STING oligomerization. • A completely different mode of action compared with current STING agonists. • Ability to inhibit a variety of viruses. [ABSTRACT FROM AUTHOR]